In most lawsuits of this nature, the company has insurance which covers the costs. The filing of lawsuits does depress the stock price, but usually more than warranted, and I believe this is the case this time. As an outlier, there is a possibility the FDA will approve Rytary prior to the resolution of the problems with the Hayward plant.
awall, good point, but as of the end of March, IPXL is actually sitting on close to $500 million based on payments that were due to the company. I expect either another product or small company to be added to the fold soon.
Investors haven't filed a single lawsuit and absolutely nothing will come of all those ambulance-chasing lawyers hoping to get a slice of some class action lawsuit action. They won't get a single penny because they'll never find a single lead Plaintiff. I've seen it dozens of times - watch and learn!